Citigroup
BBNX

Citigroup’s Beta Bionics BBNX Stock Holding History

Citigroup’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
74,055
+72,042
+3,579% +$857K ﹤0.01% 3334
2026
Q1 		$20.2K Buy
2,013
+69
+4% +$1.02K ﹤0.01% 4820
2025
Q4 		$59.2K Buy
1,944
+463
+31% +$12.4K ﹤0.01% 4511
2025
Q3 		$29.4K Sell
1,481
-3,124
-68% -$54.9K ﹤0.01% 4670
2025
Q2 		$67K Sell
4,605
-4,734
-51% -$67K ﹤0.01% 4618
2025
Q1 		$114K Buy
+9,339
New +$174K ﹤0.01% 4522

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Citigroup's BBNX Position: Q2 2026 in Review

Citigroup increased its Beta Bionics (BBNX) stake by 3,579% in Q2 2026, buying an estimated $857K and bringing the position to 74,055 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3334.

Citigroup first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Citigroup held 74,055 shares of Beta Bionics worth $1.16M as of Q2 2026.
  • Citigroup bought 72,042 Beta Bionics shares in Q2 2026, an estimated $857K.
  • Beta Bionics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3334 holding.
  • Citigroup first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.